Testing effectiveness (Phase 2)Study completedNCT02626884
What this trial is testing
Ibrutinib in Relapsed Nodular Lymphocyte-predominant Hodgkin Lymphoma (NLPHL)
Who this might be right for
Nodular Lymphocyte-Predominant Hodgkin's Lymphoma
University of Cologne 14